(Q45783851)

English

Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to alpha-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to alpha-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

G Russo-Mancuso

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

F Di Gregorio

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

E Passero

3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

A Sciotto

4

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

M C Mazzarino

5

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

G Malaponte

6

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

G Schilirò

7

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

language of work or name

0 references

publication date

1 February 1995

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

89

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

291-298

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

A pattern of 5‐1‐1 and c100‐3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Recombinant alpha-interferon treatment of non-A, and non-B (type C) hepatitis: review of studies and recommendations for treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Interferon in viral hepatitis: role in pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

A pilot study of ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Alpha interferon in the treatment of chronic hepatitis C infection in thalassaemia major

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

A long-term study of hepatitis C virus replication in non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Effects of interferon on intrahepatic human leukocyte antigens and lymphocyte subsets in patients with chronic hepatitis B and C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Second-generation anti-HCV tests predict infectivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Rapid clearance of hepatitis C virus RNA in peripheral blood mononuclear cells of patients with clotting disorders and chronic hepatitis C treated with alpha-2b interferon is not a predictor for sustained response to treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Mechanisms of action of interferons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Antibody to hepatitis C virus in 1,305 Italian multiply transfused thalassaemics: a comparison of first and second generation tests. Cooleycare Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Ribavirin treatment for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Prevalence of hepatitis C virus antibody in beta-thalassemic polytransfused children in a long-term follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Interferon for non-A, non-B chronic hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03303.X

21 January 2018

Identifiers

10.1111/J.1365-2141.1995.TB03303.X

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/7873379

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45783851&oldid=2082362581"